21股获推荐，泽璟制药、佐力药业目标价涨幅超30%丨券商评级观察

Group 1 - The core viewpoint of the article highlights that on December 15, brokerages set target prices for listed companies, with significant increases noted for certain firms [1] - The companies with the highest target price increases include Zejing Pharmaceutical at 35.00%, Zoli Pharmaceutical at 34.58%, and Genesis at 27.40%, representing the chemical pharmaceutical, traditional Chinese medicine, and automation equipment industries respectively [1] - A total of 21 listed companies received brokerage recommendations on December 15, with Zoli Pharmaceutical receiving the most recommendations at 5, while Tiandi Technology and Changbao Co. each received 1 recommendation [1]